Back to today’s briefing

Story perspectives

Rocket Lab shares drop 14% after Neutron test failure

9/9/2026

1 1 Full Breakdown

Summary

Story summary

Rocket Lab shares fell 14.11% after a Stage 1 tank test failure pushed the Neutron rocket to Q4 2026.
Analysts set an average price target of $111, implying roughly 73% upside from the $64.26 market price.
Rocket Lab raised $1.53 billion via an at-the-market equity program in H1, raising dilution concerns.
The company reported Q2 revenue of $234.07 million, up 62% YoY, while GAAP EPS of –0.08 missed expectations.

1 of 1

Story summary

Rocket Lab shares fell 14.11% after a Stage 1 tank test failure pushed the Neutron rocket to Q4 2026.
Analysts set an average price target of $111, implying roughly 73% upside from the $64.26 market price.
Rocket Lab raised $1.53 billion via an at-the-market equity program in H1, raising dilution concerns.
The company reported Q2 revenue of $234.07 million, up 62% YoY, while GAAP EPS of –0.08 missed expectations.